Segall Bryant & Hamill, LLC Abbott Laboratories Transaction History

Segall Bryant & Hamill, LLC

$7.16 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $391,099 - $469,254	-4,094 Reduced 0.84%	484,178 $46.9 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $2.03 Million - $2.27 Million	-20,175 Reduced 3.97%	488,272 $53.2 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $472,870 - $556,596	-4,882 Reduced 0.95%	508,447 $51.5 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $1.2 Million - $1.41 Million	-12,628 Reduced 2.4%	513,329 $56.4 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $1.13 Million - $1.31 Million	-11,652 Reduced 2.17%	525,957 $50.9 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $408,382 - $493,603	-4,001 Reduced 0.74%	537,609 $58.4 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $317,773 - $387,504	-2,787 Reduced 0.51%	541,610 $64.1 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $1.19 Million - $1.46 Million	-10,299 Reduced 1.86%	544,397 $76.6 Million
Q3 2021 Nov 03, 2021	SELL	$116.66 - $129.06 $132,292 - $146,354	-1,134 Reduced 0.2%	554,696 $65.5 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $5.27 Million - $6.21 Million	-49,840 Reduced 8.23%	555,830 $64.4 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $17.4 Million - $20.5 Million	-159,875 Reduced 20.88%	605,670 $72.6 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $233,100 - $254,012	2,220 Added 0.29%	765,545 $83.8 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $3.05 Million - $3.7 Million	33,230 Added 4.55%	763,325 $83.1 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $2.14 Million - $2.74 Million	-27,912 Reduced 3.68%	730,095 $66.8 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $1.23 Million - $1.8 Million	-19,602 Reduced 2.52%	758,007 $59.8 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $92,170 - $102,607	-1,174 Reduced 0.15%	777,609 $67.5 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $1.5 Million - $1.62 Million	18,310 Added 2.41%	778,783 $65.2 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $11.9 Million - $13.9 Million	163,224 Added 27.33%	760,473 $0
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $670,212 - $810,287	-10,121 Reduced 1.67%	597,249 $0
Q4 2018 Feb 15, 2019	SELL	$65.56 - $74.27 $164,031 - $185,823	-2,502 Reduced 0.41%	607,370 $43.9 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $1.27 Million - $1.53 Million	-20,911 Reduced 3.32%	609,872 $0
Q2 2018 Aug 08, 2018	BUY	$57.57 - $63.54 $16.7 Million - $18.4 Million	289,601 Added 84.88%	630,783 $0
Q1 2018 May 16, 2018	SELL	$56.27 - $63.62 $64,823 - $73,290	-1,152 Reduced 0.34%	341,182 $0
Q4 2017 Feb 15, 2018	SELL	$53.68 - $57.47 $1.14 Million - $1.22 Million	-21,168 Reduced 5.82%	342,334 $0
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $17.5 Million - $19.5 Million	363,502	363,502 $0

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account